Literature DB >> 16649840

3-acetyl-7-oxo-dehydroepiandrosterone for healing treatment-resistant posttraumatic stress disorder in women: 5 case reports.

Sharon Sageman, Richard P Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16649840     DOI: 10.4088/jcp.v67n0323b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  5 in total

1.  Chemical synthesis of 7-oxygenated 12α-hydroxy steroid derivatives to enable the biochemical characterization of cytochrome P450 8B1, the oxysterol 12α-hydroxylase enzyme implicated in cardiovascular health and obesity.

Authors:  Samuel D Offei; Hadi D Arman; Mirza Oais Baig; Lazaro S Chavez; Carlos A Paladini; Francis K Yoshimoto
Journal:  Steroids       Date:  2018-11-03       Impact factor: 2.668

Review 2.  Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.

Authors:  William Berger; Mauro V Mendlowicz; Carla Marques-Portella; Gustavo Kinrys; Leonardo F Fontenelle; Charles R Marmar; Ivan Figueira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-12-24       Impact factor: 5.067

3.  Association of DHEA, DHEAS, and cortisol with childhood trauma exposure and post-traumatic stress disorder.

Authors:  Elizabeth E Van Voorhees; Michelle F Dennis; Patrick S Calhoun; Jean C Beckham
Journal:  Int Clin Psychopharmacol       Date:  2014-01       Impact factor: 1.659

4.  DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli.

Authors:  Rebecca K Sripada; Christine E Marx; Anthony P King; Nirmala Rajaram; Sarah N Garfinkel; James L Abelson; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2013-04-03       Impact factor: 7.853

Review 5.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.